105 related articles for article (PubMed ID: 10203029)
21. Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples.
Blaak H; van't Wout AB; Brouwer M; Cornelissen M; Kootstra NA; Albrecht-van Lent N; Keet RP; Goudsmit J; Coutinho RA; Schuitemaker H
J Virol; 1998 Jan; 72(1):218-24. PubMed ID: 9420218
[TBL] [Abstract][Full Text] [Related]
22. Regulation of CCR5 and CXCR4 expression by type 1 and type 2 cytokines: CCR5 expression is downregulated by IL-10 in CD4-positive lymphocytes.
Patterson BK; Czerniewski M; Andersson J; Sullivan Y; Su F; Jiyamapa D; Burki Z; Landay A
Clin Immunol; 1999 Jun; 91(3):254-62. PubMed ID: 10370370
[TBL] [Abstract][Full Text] [Related]
23. Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4.
Taub DD; Mikovits JA; Nilsson G; Schaffer EM; Key ML; Petrow-Sadowski C; Ruscetti FW
Cell Immunol; 2004 Aug; 230(2):65-80. PubMed ID: 15598422
[TBL] [Abstract][Full Text] [Related]
24. TALENs-mediated homozygous CCR5Δ32 mutations endow CD4+ U87 cells with resistance against HIV‑1 infection.
Yu AQ; Ding Y; Lu ZY; Hao YZ; Teng ZP; Yan SR; Li DS; Zeng Y
Mol Med Rep; 2018 Jan; 17(1):243-249. PubMed ID: 29115572
[TBL] [Abstract][Full Text] [Related]
25. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
[TBL] [Abstract][Full Text] [Related]
26. CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication.
Tebas P; Jadlowsky JK; Shaw PA; Tian L; Esparza E; Brennan AL; Kim S; Naing SY; Richardson MW; Vogel AN; Maldini CR; Kong H; Liu X; Lacey SF; Bauer AM; Mampe F; Richman LP; Lee G; Ando D; Levine BL; Porter DL; Zhao Y; Siegel DL; Bar KJ; June CH; Riley JL
J Clin Invest; 2024 May; 134(9):. PubMed ID: 38690741
[No Abstract] [Full Text] [Related]
27. HIV-1 Infection in Persons Homozygous for CCR5-Δ32 Allele: The Next Case and the Review.
Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wąsik TJ
AIDS Rev; 2017 Dec; 19(4):219-230. PubMed ID: 28534889
[TBL] [Abstract][Full Text] [Related]
28. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation.
Suy A; Castro P; Nomdedeu M; García F; López A; Fumero E; Gallart T; Lopalco L; Coll O; Gatell JM; Plana M
J Infect Dis; 2007 Oct; 196(8):1191-201. PubMed ID: 17955438
[TBL] [Abstract][Full Text] [Related]
29. CCR5 Δ32 homozygous cord blood allogeneic transplantation in a patient with HIV: a case report.
Duarte RF; Salgado M; Sánchez-Ortega I; Arnan M; Canals C; Domingo-Domenech E; Fernández-de-Sevilla A; González-Barca E; Morón-López S; Nogues N; Patiño B; Puertas MC; Clotet B; Petz LD; Querol S; Martinez-Picado J
Lancet HIV; 2015 Jun; 2(6):e236-42. PubMed ID: 26423196
[TBL] [Abstract][Full Text] [Related]
30. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
Salem AH; Batzer MA
Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
[TBL] [Abstract][Full Text] [Related]
31. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels.
Heigele A; Joas S; Regensburger K; Kirchhoff F
Retrovirology; 2015 Oct; 12():86. PubMed ID: 26452480
[TBL] [Abstract][Full Text] [Related]
32. Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age.
Buseyne F; Janvier G; Teglas JP; Ivanoff S; Burgard M; Bui E; Mayaux MJ; Blanche S; Rouzioux C; Rivière Y
J Infect Dis; 1998 Oct; 178(4):1019-23. PubMed ID: 9806029
[TBL] [Abstract][Full Text] [Related]
33. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
[TBL] [Abstract][Full Text] [Related]
34. HLA class I protective alleles in an HIV-1-infected subject homozygous for CCR5-Δ32/Δ32.
Ballana E; Riveira-Munoz E; Pou C; Bach V; Parera M; Noguera M; Santos JR; Badia R; Casadellà M; Clotet B; Paredes R; Martínez MA; Brander C; Esté JA
Immunobiology; 2013 Apr; 218(4):543-7. PubMed ID: 22818666
[TBL] [Abstract][Full Text] [Related]
35. Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
van Rij RP; Blaak H; Visser JA; Brouwer M; Rientsma R; Broersen S; de Roda Husman AM; Schuitemaker H
J Clin Invest; 2000 Oct; 106(8):1039-52. PubMed ID: 11032864
[TBL] [Abstract][Full Text] [Related]
36. Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women.
Mnqonywa N; Abbai N; Ragupathy V; Ramjee G; Hewlett I; Moodley D
BMC Res Notes; 2019 Nov; 12(1):745. PubMed ID: 31730016
[TBL] [Abstract][Full Text] [Related]
37. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy.
Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A
J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786
[TBL] [Abstract][Full Text] [Related]
38. Effects of human immunodeficiency virus type 1 infection on CCR5 and CXCR4 coreceptor expression on CD4 T lymphocyte subsets in infants and adolescents.
Tuttle DL; Coberley CR; Xie X; Kou ZC; Sleasman JW; Goodenow MM
AIDS Res Hum Retroviruses; 2004 Mar; 20(3):305-13. PubMed ID: 15117454
[TBL] [Abstract][Full Text] [Related]
39. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
[TBL] [Abstract][Full Text] [Related]
40. [Deep lung--cellular reaction to HIV].
Tavares Marques MA; Alves V; Duque V; Botelho MF
Rev Port Pneumol; 2007; 13(2):175-212. PubMed ID: 17492233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
